Systemic antifungal therapy with isavuconazonium sulfate or other agents in adults with invasive mucormycosis or invasive aspergillosis (non-fumigatus): A multicentre, non-interventional registry study.
George R Thompson IiiJulia Garcia-DiazMarisa H MiceliM Hong NguyenLuis Ostrosky-ZeichnerJo-Anne H YoungCynthia E FisherNina M ClarkRichard N GreenbergAndrej SpecLaura KovandaRodney Croos-DabreraDimitrios P KontoyiannisPublished in: Mycoses (2021)
This study supports the effectiveness and tolerability of ISAVUSULF in clinical practice. Further research is required to confirm the value of ISAVUSULF combination therapy over monotherapy.